TABLE 1.
Treatment | Tumor incidence | ||||
---|---|---|---|---|---|
Male | Female | ||||
Zhx2 wt | Zhx2 KO | Zhx2 wt | Zhx2 KO | ||
9 months | PBS | 0% (0 of 15) | 0% (0 of 9) | 0% (0 of 14) | 0% (0 of 10) |
DEN | 100% (14 of 14) | 0% (0 of 11) | 25% (3 of 12) | 0% (0 of 10) | |
10 months | PBS | 0% (0 of 10) | 0% (0 of 11) | 0% (0 of 9) | 0% (0 of 10) |
DEN | 100% (10 of 10) | 0% (0 of 11) | 36% (4 of 11) | 0% (0 of 11) |
Note: Zhx2 KO mice and Zhx2 wt littermates were given a single intraperitoneal injection of DEN (10 mg/kg; Sigma‐Aldrich) or vehicle (PBS) at 14 days of age. Livers were removed and tumor loads were examined 9 or 10 months after DEN exposure. Number of mice with tumor/cohort in parentheses.